Non-surgical therapies provide a safe, effective and durable treatment option for patients with moderate-to-severe symptoms of BPH. In-office BPH treatment options involve performing a single, non-surgical procedure in less than one hour comfortably managed without the need for general anesthesia. In-office BPH treatment options are ideal for patients who do not want to take daily medications for the rest of their lives, dislike the side effects and ongoing costs of medication or do not want the risks, side effects or high costs of invasive surgery.
As with any medical procedure, there are potential risks and side effects that can occur with in-office medical procedures. We’re committed to providing the information you and your patients need to make a well-informed BPH treatment decisions. Although these problems rarely occur, we want you to know the facts. Please refer to the Cooled ThermoTherapy™ and Prostiva® RF Therapy sections to learn about the benefits and risks specifically associated with procedures.
Urologix offers two versatile minimally invasive treatment options:
Cooled ThermoTherapy™ (CTT), also known as transurethral microwave thermotherapy (TUMT), is optimal for controlled treatment in a broad patient population. CTT is a targeted therapy that achieves deep tissue necrosis in a single 28.5 minute treatment.1 It includes an advanced cooling design providing enhanced protection for the healthy urethra as well as increased patient comfort. CTT provides durable results with no reintervention required in over 90% of patients at five years.2
Prostiva® RF Therapy, also known as transurethral needle ablation (TUNA), is most advantageous for direct visualization and treatment of complex anatomy and smaller glands. Prostiva uses radio frequency needles placed directly into the prostate to generate heat and cause coagulation. Prostiva provides durable results with no reintervention required in over 86% of patients at five years.3
Both treatments combined provide a complete BPH solution for your patients. Not sure which option is best for your patient? Watch our Technology Animation to help you decide.
The figure below, published in the AUA clinical guidance document, shows the impact of minimally invasive therapy on patient bother as measured by symptom score, peak flow rate, QoL score, and BPH impact Index.4
Note: The data for BPH Medications, Cooled ThermoTherapy, and PROSTIVA were not collected in a head-to-head study. Direct comparisons cannot be made.
1 CTC Advance Instructions for Use, 250348 Rev D. 8/10 2Mynderse, L., et al, 5 year Results of a Multi-Center Trial of a New Generation Cooled TUMTfor BPH, Journal of Urology, May 2001 3Hill, B., et al Transurethreal Needle Ablation vs TURP for the Treatment of Symptomatic BPH: 5 Year Results of a Prospective, Randomized, Multicenter Clinical Trial, Journal of Urology Vol 171, 2336-2340, June 2004 4AUA Clinical Guidelines on the Management of BPH (Revised, 2010) 5Data from online survey conducted by Harris Interactive, August 2007 sponsored by Medtronic, Inc. Survey included 206 qualified respondents.